[HTML][HTML] Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer

N Vainer, C Dehlendorff, JS Johansen - Oncotarget, 2018 - ncbi.nlm.nih.gov
Gastrointestinal cancer (GI) is a major health problem. Patients with gastric, pancreatic,
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …

A systematic review of the association between circulating concentrations of C reactive protein and cancer

K Heikkilä, S Ebrahim, DA Lawlor - Journal of Epidemiology & …, 2007 - jech.bmj.com
The objective of this study was to review and summarise the published evidence for an
association between circulating concentrations of C reactive protein (CRP) and cancer …

Biomarkers in the critically ill patient: procalcitonin

K Reinhart, M Meisner - Critical care clinics, 2011 - criticalcare.theclinics.com
PCT differs from other propsed sepsis markers such as cytokines, C-reactive protein (CRP),
or lipopolysaccharide-binding protein (LBP) primarily by the fact that it better reflects the …

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer

DK Kim, SY Oh, HC Kwon, S Lee, KA Kwon, BG Kim… - BMC cancer, 2009 - Springer
Abstract Background The interleukin-6 (IL-6) pathway is one of the mechanisms that link
inflammation and angiogenesis to malignancy. Because the C-reactive protein (CRP) is a …

CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial

J Lu, B Xu, Z Zheng, J Xie, J Wang, J Lin, Q Chen… - Gastric Cancer, 2019 - Springer
Background Serum prealbumin (PALB) can predict the prognosis of patients with gastric
cancer (GC). However, the prognostic value of combination of C-reactive protein and PALB …

Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer

S Kılınçalp, F Ekiz, Ö Başar, MR Ayte, Ş Çoban… - Platelets, 2014 - Taylor & Francis
Gastric cancer is the fourth most frequent cancer and the second cause of cancer-related
deaths worldwide. The early diagnosis of gastric cancer is fundamental in decreasing the …

Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer

L Lian, YY Xia, C Zhou, XM Shen, XL Li… - Cancer …, 2015 - content.iospress.com
BACKGROUND: Gastric cancer is the fourth most frequent cancer and the second cause of
cancer-related deaths worldwide. China has a high incidence of gastric cancer …

Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer

L Cramer, B Hildebrandt, T Kung, K Wichmann… - Journal of the American …, 2014 - jacc.org
Background: Patients with colorectal cancer (CRC) often present with dyspnea and fatigue.
These are also frequent symptoms in patients with chronic heart failure (CHF). Objectives …

Dynamic changes in pre-and postoperative levels of inflammatory markers and their effects on the prognosis of patients with gastric cancer

JX Lin, ZK Wang, YQ Huang, JW Xie, JB Wang… - Journal of …, 2021 - Elsevier
Background Whether the change of the pre-and postoperative systemic inflammatory
response (SIR) levels will affect the prognosis of gastric cancer (GC) is unclear. We aimed to …

Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study

C Cheng, Q Zhang, LP Zhuang… - Japanese journal of …, 2020 - academic.oup.com
Objective The immune inflammation-based score is recognized as a prognostic marker for
cancer. However, the most accurate prognostic marker for patients with gastric cancer …